Sen. Warren Wants FTC Scrutiny Of $29B Pharma Deals
Sen. Elizabeth Warren, D-Mass. has urged the Federal Trade Commission to look closely at two pending pharmaceutical mergers, insisting that the deals could lead to higher drug prices and prevent "affordable...To view the full article, register now.
Already a subscriber? Click here to view full article